keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LTX-315 (Oncopore), the oncolytic peptide, inhibits cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | お問い合わせ | ¥ 14,500 |
2 mg | お問い合わせ | ¥ 20,500 |
5 mg | お問い合わせ | ¥ 29,000 |
10 mg | お問い合わせ | ¥ 49,500 |
25 mg | お問い合わせ | ¥ 90,500 |
50 mg | お問い合わせ | ¥ 134,500 |
説明 | LTX-315 (Oncopore), the oncolytic peptide, inhibits cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization. |
ターゲット&IC50 | A20:8.3 μM, AT84:11 μM, MRC5:34.3 μM |
In vitro | LTX-315 is highly active against both murine and human melanoma cell lines in vitro. while displaying low EC50 cytotoxic activity against human red blood cells. LTX-315 has been shown to induce the release of ATP and HMGB1 in vitro, both being DAMPs involved in ICD[1]. |
In vivo | when syngeneic B16 melanomas are treated intralesionally, a majority of the animals (~80%) treated with LTX-315 experience a complete and long-lasting tumor regression. LTX-315 injection induces an extensive hemorrhagic necrosis of the tumor parenchyma and a massive infiltration of CD3+ T cells, indicating that the peptide induces a type of cell death that leads to an increase in the number of tumor-infiltrating lymphocytes (TILs). treatment of a single tumor with LTX-315 generates a systemic anti-tumor immune response that eradicated distant lesions and prevented reoccurrence following tumor rechallenge[1]. |
細胞研究 | LTX-315 is prepared in FBS-free culture medium.Tumor cells are incubated for 4 hours with 10 concentrations of LTX-315 in 1/4 dilution step with a top dose of 400 μM, with 1% (final concentration) Triton X-100 as positive control and FBS-free culture medium as negative control. Cell cytotoxicity is measured using the MTS assay |
動物実験 | LTX-315 is dissolved in saline.Mice: Tumor cells are harvested, ished in RPMI-1640 and injected intradermally (i.d.) into the right side of the abdomen in C57BL/6 mice. Palpable tumors are injected i.t. with single doses of LTX-315 or LTX-328 dissolved in saline (1.0 mg peptide/50 μL saline) once a day for 3 consecutive days, and the vehicle control is saline only (0.9% NaCl in sterile water). Tumor size is measured using an electronic caliper |
別名 | LTX315, Oncopore, K-K-W-W-K-K-W-Dip-K-NH2 |
分子量 | 1439.79 |
分子式 | C78H106N18O9 |
CAS No. | 1345407-05-7 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10mM
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LTX-315 1345407-05-7 Apoptosis BCL LTX 315 LTX315 Oncopore K-K-W-W-K-K-W-Dip-K-NH2 Inhibitor inhibitor inhibit